Medibank Private Ltd shares face regulatory headwinds in 2016

Medibank Private Ltd (ASX:MPL) could face a flat 2016.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shares in private health insurance giant Medibank Private Ltd (ASX: MPL) traded flat today as the business passes two years as a public entity to sell for $2.10 a smidgen above the $2 retail offer price at the IPO stage back in 2014.

The stock has traded as high as $2.59 as investors got excited about the company's ability to potentially lift margins via cost cutting as it transitions from a government business enterprise to ASX top 100 company.

Medibank has succeeded in cutting its management expense ratio as a private enterprise and posted a pro forma net profit of $292 million in FY15, up 12.9% over the prior year.

However, the business faces challenges in the year ahead with the Fairfax press today reporting a spokesman for the government's Health Minister Sussan Ley as saying on private health insurance: "The Minister maintains her concern about the growing number of junk policies and hidden catches…The government is focused on getting the balance right between ensuring strong competition and high-quality, straight-talking health cover."

The potential for regulatory reform in the sector is likely to make Medibank investors nervous, while the group also faces a battle in persuading Australians already feeling the pinch thanks to flat wages growth to maintain their private health cover, when there is a largely free healthcare system as an alternative.

However, the public Medicare system also looks set for government cutbacks, while Medibank itself is also putting pressure on hospitals to more effectively manage costs that are sent to the insurer as billings.

Given the potential headwinds the group's valuation on around 18x analysts' estimates for earnings is probably about fair value, as this is a reasonable quality business with plenty of levers to pull in the quest to lift profit.

Another private health insurance business for investors to consider is NIB Holdings Limited (ASX: NHF). It faces similar opportunities and challenges to Medibank, with both businesses reasonable prospects at the right price for conservative investors.

Motley Fool contributor Tom Richardson has no position in any stocks mentioned. You can find Tom on Twitter @tommyr345 Unless otherwise noted, the author does not have a position in any stocks mentioned by the author in the comments below. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »